Weight loss

Retatrutide, simplified.

Also called "GLP-3", triple agonist

Human studies

An experimental weight-loss drug that copies three hormones at once. It has produced the largest weight loss seen so far in trials, but it is not approved yet.

Size
39 amino acids
How it is taken
Weekly injection (in trials)
Status
Investigational, not approved

What is it?

Retatrutide acts on three hormone signals: GLP-1, GIP and glucagon. The glucagon part may help the body burn more energy, on top of eating less.

What studies show

What we don’t know yet

Side effects and cautions

Is it legal?

Common questions

What is Retatrutide?

An experimental weight-loss drug that copies three hormones at once. It has produced the largest weight loss seen so far in trials, but it is not approved yet. Retatrutide acts on three hormone signals: GLP-1, GIP and glucagon. The glucagon part may help the body burn more energy, on top of eating less.

What does the research say about Retatrutide?

In its first large Phase 3 trial, people on the top dose lost around 28 to 30% of their body weight on average. It also eased knee osteoarthritis pain in people with obesity in that trial.

Is Retatrutide FDA approved?

Not FDA-approved. Only legally available inside clinical trials.

What are the side effects of Retatrutide?

Stomach side effects similar to other GLP-1 drugs. Products sold online as "research retatrutide" are not the tested drug and have no quality control.

Related peptides

Not sure where to start?

Answer 8 quick questions and see which peptides the research points to for your goal.

Find my stack

This page explains published research in plain language. It is not medical advice, a diagnosis, or a recommendation to take anything, and it does not give dosing. Most peptides here are not FDA-approved, and products sold online vary widely in purity. Rules around peptides are changing, so check the current status and talk with a licensed clinician before starting anything. Last reviewed 2026-09-26.